Logos Global Management LP - 26 Mar 2026 SCHEDULE 13G Report for Avalo Therapeutics, Inc. Common Stock (AVTX)
- Filing Manager
- Logos Global Management LP
- Reporting Manager
- Logos Global Management LP
- Symbol
- AVTX
- Shares outstanding
- 22,946,429 shares
- Disclosed Ownership
- 1,285,000 shares
- Ownership
- 5.6%
- Form type
- SCHEDULE 13G
- Filing time
- 01 Apr 2026, 13:02:57 UTC
- Date of event
- 26 Mar 2026
- SEC
- View on sec.gov
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Logos Global Management LP | 5.6% | 1,285,000 | 0 | 1,285,000 | /s/ Arsani William | Managing Partner | |
| Logos Global Management GP LLC | 5.6% | 1,285,000 | 0 | 1,285,000 | /s/ Arsani William | Managing Member | |
| Logos Global Master Fund LP | 5.6% | 1,285,000 | 0 | 1,285,000 | /s/ Arsani William | Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP | |
| Logos GP LLC | 5.6% | 1,285,000 | 0 | 1,285,000 | /s/ Arsani William | Managing Member | |
| Arsani William | 5.6% | 1,285,000 | 0 | 1,285,000 | /s/ Arsani William | Reporting person |